Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05429762 |
| Title | Effect of Tusamitamab Ravtansine on QTc Interval in Participants With Metastatic Solid Tumors (TusaRav-QT) |
| Acronym | TusaRav-QT |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Sanofi |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | TUR | FRA | ESP | BEL |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Mary Crowley Cancer Research Center Site Number : 8400002 | Dallas | Texas | 75230 | United States | Details | |
| Investigational Site Number : 0560001 | Edegem | 2650 | Belgium | Details | ||
| Investigational Site Number : 2500001 | Dijon | 21079 | France | Details | ||
| Investigational Site Number : 2500002 | Marseille | 13385 | France | Details | ||
| Investigational Site Number : 7240002 | Barcelona | Catalunya [Cataluña] | 08023 | Spain | Details | |
| Investigational Site Number : 7240001 | Madrid | Madrid, Comunidad De | 28040 | Spain | Details | |
| Investigational Site Number : 7920001 | Ankara | 06800 | Turkey | Details |